About this Journal Submit a Manuscript Table of Contents
International Journal of Alzheimer’s Disease
Volume 2012 (2012), Article ID 578373, 7 pages
http://dx.doi.org/10.1155/2012/578373
Review Article

Tau Phosphorylation by GSK3 in Different Conditions

1Centro de Biologia Molecular “Severo Ochoa” (CSIC-UAM), Nicolás Cabrera 1, Campus Cantoblanco UAM, 28049 Madrid, Spain
2Centro de Investigación Biomédica en Red de Enfermedades neurodegenerativas (CIBERNED), 28031 Madrid, Spain
3Instituto Cajal, Consejo Superior de Investigaciones Científicas, 28002 Madrid, Spain
4Laboratorio Cajal de Circuitos Corticales, Centro de Tecnología Biomédica, Universidad Politécnica de Madrid, 28223 Madrid, Spain

Received 17 January 2012; Accepted 15 March 2012

Academic Editor: Hanna Rosenmann

Copyright © 2012 Jesús Avila et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [10 citations]

The following is the list of published articles that have cited the current article.

  • Teresa Rodríguez-Martín, Inmaculada Cuchillo-Ibáñez, Wendy Noble, Fanon Nyenya, Brian H. Anderton, and Diane P. Hanger, “Tau phosphorylation affects its axonal transport and degradation,” Neurobiology of Aging, vol. 34, no. 9, pp. 2146–2157, 2013. View at Publisher · View at Google Scholar
  • Juliana B. Hoppe, Karine Coradini, Rudimar L. Frozza, Claudia M. Oliveira, André B. Meneghetti, Andressa Bernardi, Elisa Simões Pires, Ruy C.R. Beck, and Christianne G. Salbego, “Free and nanoencapsulated curcumin suppress β-amyloid-induced cognitive impairments in rats: involvement of BDNF and Akt/GSK-3β signaling pathway,” Neurobiology of Learning and Memory, 2013. View at Publisher · View at Google Scholar
  • Paula Merino-Serrais, Ruth Benavides-Piccione, Lidia Blazquez-Llorca, Asta Kastanauskaite, Alberto Rábano, Jesús Avila, and Javier Defelipe, “The influence of phospho-tau on dendritic spines of cortical pyramidal neurons in patients with Alzheimer's disease,” Brain, vol. 136, no. 6, pp. 1913–1928, 2013. View at Publisher · View at Google Scholar
  • Nicolas Dzamko, and Glenda M Halliday, “Unlocking the secrets of LRRK2 function with selective kinase inhibitors,” Future Neurology, vol. 8, no. 3, pp. 347–357, 2013. View at Publisher · View at Google Scholar
  • Wolfgang Froestl, Andreas Muhs, and Andrea Pfeifer, “Cognitive enhancers (nootropics). Part 2: Drugs interacting with enzymes,” Journal of Alzheimer's Disease, vol. 33, no. 3, pp. 547–658, 2013. View at Publisher · View at Google Scholar
  • Miguel Medina, Jesus Avila, and Nieves Villanueva, “Use of Okadaic Acid to Identify Relevant Phosphoepitopes in Pathology: A Focus on Neurodegeneration,” Marine Drugs, vol. 11, no. 5, pp. 1656–1668, 2013. View at Publisher · View at Google Scholar
  • Lilian Calderón-Garcidueñas, Maricela Franco-Lira, Antonieta Mora-Tiscareño, Humberto Medina-Cortina, Ricardo Torres-Jardón, and Michael Kavanaugh, “Early Alzheimer’s and Parkinson’s Disease Pathology in Urban Children: Friend versus Foe Responses—It Is Time to Face the Evidence,” BioMed Research International, vol. 2013, pp. 1–16, 2013. View at Publisher · View at Google Scholar
  • Sergio Camero, Maria J. Benitez, Raquel Cuadros, Felix Hernandez, Jesus Avila, and Juan S. Jimenez, “Thermodynamics of the Interaction between Alzheimer's Disease Related Tau Protein and DNA,” Plos One, vol. 9, no. 8, 2014. View at Publisher · View at Google Scholar
  • M. Geetha, V. Kalaivani, P. S. Sabarinath, and P. S. Appukuttan, “Plasma anti-alpha-galactoside antibody binds to serine- and threonine-rich peptide sequence of apo(a) subunit in Lp(a),” Glycoconjugate Journal, vol. 31, no. 4, pp. 289–298, 2014. View at Publisher · View at Google Scholar
  • Erin L. Cole, Xia Shao, Phillip Sherman, Carole Quesada, Maria V. Fawaz, Timothy J. Desmond, and Peter J.H. Scott, “Synthesis and evaluation of [11C]PyrATP-1, a novel radiotracer for PET imaging of glycogen synthase kinase-3β (GSK-3β),” Nuclear Medicine and Biology, 2014. View at Publisher · View at Google Scholar